Cyclosporin-induced haemolytic-uraemic syndrome presenting as primary graft dysfunction
نویسندگان
چکیده
منابع مشابه
Cyclosporin-induced haemolytic-uraemic syndrome presenting as primary graft dysfunction.
anastomosed (end to side) to the external iliac vein Introduction and the renal artery to the internal iliac artery. After declamping, two small patches of bluish discoloration Although the efficacy of cyclosporin (CsA) as an of the graft were noted, which did not increase and immunosuppressant is undisputed, the problem of there was adequate diuresis. One hour after the ananephrotoxicity conti...
متن کاملHaemolytic-uraemic syndrome presenting as an acute abdomen.
Haemolytic-uraemic syndrome (HUS) may present with symptoms and signs suggestive of an acute surgical condition of the abdomen. The patient described was admitted with clinical features sufficient to warrant operation but later proved to have HUS.
متن کاملLeptospirosis presenting as haemolytic uraemic syndrome: a case report
BACKGROUND Leptospirosis is a rare infectious disease especially in Western Countries. Renal involvement is a recognised complication of leptospirosis but leptospirosis-associated haemolytic uraemic syndrome is extremely rare and to our knowledge has only been reported once, in 1985. CASE PRESENTATION A 29-year-old male was transferred to our Renal Unit with fevers, myalgia and diarrhoeal ill...
متن کاملUneventful re-treatment with cyclosporin in two cases of cyclosporin-induced haemolytic uraemic syndrome.
Key words: cyclosporin; haemolytic uraemic syndrome; day 2 was discontinued the same day, as laboratory studies revealed a Coombs-negative microangiopathic renal transplantation; thrombotic microangiopathy haemolytic anaemia (MAHA) with thrombopenia: haemoglobin decreased to 6.8 from 8.5 g/dl (D1), lactate dehydrogenase (LDH) increased to 987 from Introduction 140 IU/l (D1), very low haptoglobi...
متن کاملEculizumab and drug-induced haemolytic–uraemic syndrome
The monoclonal anti-C5 antibody eculizumab has been successfully tested in atypical haemolytic-uraemic syndrome (aHUS), with or without mutations in the regulatory proteins of the alternative pathway of the complement, and less convincingly in enterohaemorrhagic Escherichia coli-associated HUS. Here, we report a patient with mitomycin-C-induced HUS unresponsive to plasma exchanges. Eculizumab i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 1998
ISSN: 0931-0509,1460-2385
DOI: 10.1093/ndt/13.11.2940